Search

Your search keyword '"Freixa-Pamias, Román"' showing total 48 results

Search Constraints

Start Over You searched for: Author "Freixa-Pamias, Román" Remove constraint Author: "Freixa-Pamias, Román"
48 results on '"Freixa-Pamias, Román"'

Search Results

1. Obesidad y enfermedad cardiovascular y renal. Posicionamiento de las Asociaciones de Cardiología Preventiva, Cardiología Clínica e Insuficiencia Cardiaca de la SEC

7. Adverse Clinical Outcomes and Associated Predictors in Rivaroxaban-Treated Atrial Fibrillation Patients With Renal Impairment

10. Tendencias actuales en el tratamiento antitrombótico

12. Cardiovascular considerations on recreational scuba diving. SEC-Clinical Cardiology Association/SEC-Working Group on Sports Cardiology consensus document

13. Diagnosis and treatment of patients with ANOCA

14. Diagn�stico y tratamiento de los pacientes con ANOCA.

18. Selection of the best of 2022 in clinical cardiology and cardiovascular pharmacotherapy

19. Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR study

20. Rivaroxaban for the prevention of outcomes in patients with atrial fibrillation in clinical practice: an indirect comparison of national and international registries

21. Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry

23. Use of rivaroxaban attenuates renal function impairment in patients with atrial fibrillation: insights of the EMIR study

25. Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR study.

28. Epidemiology of atrial fibrillation-related ischemic stroke and its association with DOAC uptake in Spain: first national population-based study 2005 to 2018

29. Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry

30. Epidemiology of atrial fibrillation-related ischemic stroke and its association with DOAC uptake in Spain: first national population-based study 2005 to 2018.

32. Impact of prescription patterns of antithrombotic treatment on atrial fibrillation-related ischemic stroke

33. implantació d'un model d'Atenció Integrada de Cardiologia - Atenció Primària en l'abordatge de pacients amb malalties cardáques cròniques

34. implantació d’un model d’Atenció Integrada de Cardiologia – Atenció Primària en l'abordatge de pacients amb malalties cardáques cròniques

35. Study design of Heart failure Events reduction with Remote Monitoring and eHealth Support (HERMeS)

36. Prevención del ictus en pacientes con fibrilación auricular. Mejorar la protección enla era de la COVID-19

37. Mejorar la prevención de la trombosis y las complicaciones cardiovasculares durante la pandemia de COVID-19

38. Anticoagulación del paciente anciano pluripatológico con fibrilación auricular no valvular: papel del rivaroxabán

41. Impact of an integral assistance model between primary care and cardiology on the management of patients with ischemic heart disease or atrial fibrillation

42. Impact of prescription patterns of antithrombotic treatment on atrial fibrillation-related ischemic stroke.

43. Uso de nuevas terapias hipolipemiantes en la práctica clínica. Consenso SEC/SEA/SEEN/SEMFYC/SEMERGEN/SEMG/SEN/SEACV/S.E.N

44. Epidemiología del ictus cardioembólico y su asociación con la penetración de los ACOD en España: primer estudio poblacional 2005-2018

45. Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry.

46. Study design of Heart failure Events reduction with Remote Monitoring and eHealth Support (HERMeS).

Catalog

Books, media, physical & digital resources